• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells.趋化因子可诱导人多形核细胞快速释放白细胞介素1 II型诱饵受体。
J Exp Med. 1995 Jun 1;181(6):2181-6. doi: 10.1084/jem.181.6.2181.
2
Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine.环孢菌素H是一种强效且具有选择性的竞争性拮抗剂,可抑制N-甲酰甲硫氨酰-亮氨酰-苯丙氨酸对人嗜碱性粒细胞的激活作用。
J Allergy Clin Immunol. 1996 Jul;98(1):152-64. doi: 10.1016/s0091-6749(96)70237-3.
3
Characterization of a 64-kd protein phosphorylated during chemotactic activation with IL-8 and fMLP of human polymorphonuclear leukocytes. I. Phosphorylation of a 64-kd protein and other proteins.人多形核白细胞在白细胞介素-8和N-甲酰甲硫氨酰-亮氨酰-苯丙氨酸趋化激活过程中磷酸化的64-kd蛋白的特性。I. 64-kd蛋白和其他蛋白的磷酸化
J Leukoc Biol. 1993 Jul;54(1):1-9. doi: 10.1002/jlb.54.1.1.
4
Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.在甲酰甲硫氨酰亮氨酰苯丙氨酸诱导的趋化作用过程中,人中性粒细胞FcγRIIIB和甲酰肽受体在功能上相互关联。
J Immunol. 1992 Aug 1;149(3):989-97.
5
In vivo and in vitro assessment of porcine neutrophil activation responses to chemoattractants: flow cytometric evidence for the selective absence of formyl peptide receptors.猪中性粒细胞对趋化因子激活反应的体内和体外评估:甲酰肽受体选择性缺失的流式细胞术证据
J Leukoc Biol. 1990 Apr;47(4):355-65. doi: 10.1002/jlb.47.4.355.
6
Various authentic chemoattractants mediating leukocyte adherence inhibition.多种介导白细胞黏附抑制的真实趋化因子。
J Natl Cancer Inst. 1984 Sep;73(3):595-605.
7
Altered function and surface marker expression of neutrophils induced by rhG-CSF treatment in severe congenital neutropenia.重组人粒细胞集落刺激因子治疗严重先天性中性粒细胞减少症时中性粒细胞功能及表面标志物表达的改变
Eur J Haematol. 1992 Jan;48(1):10-9. doi: 10.1111/j.1600-0609.1992.tb01787.x.
8
Fibrin regulates neutrophil migration in response to interleukin 8, leukotriene B4, tumor necrosis factor, and formyl-methionyl-leucyl-phenylalanine.纤维蛋白可调节中性粒细胞对白细胞介素8、白三烯B4、肿瘤坏死因子和甲酰甲硫氨酰亮氨酰苯丙氨酸的迁移反应。
J Exp Med. 1995 May 1;181(5):1763-72. doi: 10.1084/jem.181.5.1763.
9
IL-8 production by human polymorphonuclear leukocytes. The chemoattractant formyl-methionyl-leucyl-phenylalanine induces the gene expression and release of IL-8 through a pertussis toxin-sensitive pathway.人多形核白细胞产生白细胞介素-8。趋化因子甲酰甲硫氨酰亮氨酰苯丙氨酸通过百日咳毒素敏感途径诱导白细胞介素-8的基因表达及释放。
J Immunol. 1992 May 15;148(10):3216-20.
10
Chemoattractant cross-desensitization of the human neutrophil IL-8 receptor involves receptor internalization and differential receptor subtype regulation.人中性粒细胞白细胞介素-8受体的趋化因子交叉脱敏涉及受体内化和不同受体亚型调控。
J Immunol. 1997 Feb 1;158(3):1361-9.

引用本文的文献

1
Molecular Basic of Pharmacotherapy of Cytokine Imbalance as a Component of Intervertebral Disc Degeneration Treatment.细胞因子失衡的药物治疗分子基础,作为椎间盘退变治疗的一个组成部分。
Int J Mol Sci. 2023 Apr 22;24(9):7692. doi: 10.3390/ijms24097692.
2
Negative Regulation of the IL-1 System by IL-1R2 and IL-1R8: Relevance in Pathophysiology and Disease.白细胞介素-1 系统的负调控:白细胞介素-1R2 和白细胞介素-1R8 的作用及其在病理生理学和疾病中的相关性。
Front Immunol. 2022 Feb 8;13:804641. doi: 10.3389/fimmu.2022.804641. eCollection 2022.
3
Neutrophil Homeostasis and Emergency Granulopoiesis: The Example of Systemic Juvenile Idiopathic Arthritis.中性粒细胞稳态和应急粒细胞生成:以全身型幼年特发性关节炎为例。
Front Immunol. 2021 Dec 13;12:766620. doi: 10.3389/fimmu.2021.766620. eCollection 2021.
4
Regulation of IL-1 signaling by the decoy receptor IL-1R2.IL-1R2 对 IL-1 信号的调控。
J Mol Med (Berl). 2018 Oct;96(10):983-992. doi: 10.1007/s00109-018-1684-z. Epub 2018 Aug 15.
5
Tuning inflammation and immunity by the negative regulators IL-1R2 and IL-1R8.通过负向调节因子 IL-1R2 和 IL-1R8 来调节炎症和免疫。
Immunol Rev. 2018 Jan;281(1):233-247. doi: 10.1111/imr.12609.
6
Cytokine decoy and scavenger receptors as key regulators of immunity and inflammation.细胞因子诱饵受体和清道夫受体作为免疫和炎症的关键调节因子。
Cytokine. 2016 Nov;87:37-45. doi: 10.1016/j.cyto.2016.06.023. Epub 2016 Aug 4.
7
Neutrophil-Mediated Phagocytosis of Staphylococcus aureus.中性粒细胞介导的金黄色葡萄球菌吞噬作用
Front Immunol. 2014 Sep 26;5:467. doi: 10.3389/fimmu.2014.00467. eCollection 2014.
8
Decoys and Regulatory "Receptors" of the IL-1/Toll-Like Receptor Superfamily.白细胞介素 1/Toll 样受体超家族的诱饵和调节“受体”。
Front Immunol. 2013 Jul 9;4:180. doi: 10.3389/fimmu.2013.00180. eCollection 2013.
9
IL-1 receptor 2 (IL-1R2) and its role in immune regulation.白细胞介素-1 受体 2(IL-1R2)及其在免疫调节中的作用。
Brain Behav Immun. 2013 Aug;32:1-8. doi: 10.1016/j.bbi.2012.11.006. Epub 2012 Nov 27.
10
IL-12-STAT4-IFN-gamma axis is a key downstream pathway in the development of IL-13-mediated asthma phenotypes in a Th2 type asthma model.IL-12-STAT4-IFN-γ 轴是 Th2 型哮喘模型中 IL-13 介导的哮喘表型发展的关键下游途径。
Exp Mol Med. 2010 Aug 31;42(8):533-46. doi: 10.3858/emm.2010.42.8.054.

本文引用的文献

1
Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4.白细胞介素-1Ⅱ型受体:一种受白细胞介素-4调节的白细胞介素-1诱饵靶点。
Science. 1993 Jul 23;261(5120):472-5. doi: 10.1126/science.8332913.
2
Interleukin 1 signaling occurs exclusively via the type I receptor.白细胞介素1信号传导仅通过I型受体发生。
Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6155-9. doi: 10.1073/pnas.90.13.6155.
3
Tumor necrosis factor induces a selective shedding of its p75 receptor from human neutrophils.肿瘤坏死因子诱导人中性粒细胞选择性脱落其p75受体。
J Biol Chem. 1994 Jan 28;269(4):2834-40.
4
The type II "receptor" as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor.II型“受体”作为多形核白细胞中白细胞介素1的诱饵靶点:地塞米松诱导特性及释放的诱饵受体的配体结合特性
J Exp Med. 1994 Feb 1;179(2):739-43. doi: 10.1084/jem.179.2.739.
5
Interleukin-13 induces expression and release of interleukin-1 decoy receptor in human polymorphonuclear cells.白细胞介素-13诱导人多形核细胞中白细胞介素-1诱饵受体的表达和释放。
J Biol Chem. 1994 Apr 29;269(17):12403-6.
6
The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1.II型“诱饵”受体:白细胞介素1的一种新型调节途径。
Immunol Today. 1994 Dec;15(12):562-6. doi: 10.1016/0167-5699(94)90217-8.
7
Absence of inflammatory lung injury in rabbits challenged intravascularly with complement-derived chemotactic factors.用补体衍生趋化因子进行血管内攻击的家兔未出现炎症性肺损伤。
Am Rev Respir Dis. 1982 Mar;125(3):335-40. doi: 10.1164/arrd.1982.125.3.335.
8
A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration.一种用于快速准确测量白细胞迁移的48孔微量化学趋化性组件。
J Immunol Methods. 1980;33(3):239-47. doi: 10.1016/0022-1759(80)90211-2.
9
IL-1 stimulates IL-6 production in endothelial cells.白细胞介素-1刺激内皮细胞产生白细胞介素-6。
J Immunol. 1989 Jan 15;142(2):549-53.
10
Expression of c-jun protooncogene in human myelomonocytic cells.c-jun原癌基因在人骨髓单核细胞中的表达。
Blood. 1989 Oct;74(5):1811-6.

趋化因子可诱导人多形核细胞快速释放白细胞介素1 II型诱饵受体。

Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells.

作者信息

Colotta F, Orlando S, Fadlon E J, Sozzani S, Matteucci C, Mantovani A

机构信息

Istituto di Ricerche Farmacologiche Mario Negri, Centro Daniela e Catullo Borgomainerio, Milano, Italy.

出版信息

J Exp Med. 1995 Jun 1;181(6):2181-6. doi: 10.1084/jem.181.6.2181.

DOI:10.1084/jem.181.6.2181
PMID:7760005
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2192047/
Abstract

Molecules representative of different classes of chemotactic agents, including formyl-Met-Leu-Phe (FMLP), C5a, leukotriene B4, platelet-activating factor, and interleukin (IL)-8, caused a rapid reduction in the IL-1 binding capacity by human polymorphonuclear leukocytes (PMN), a cell type expressing predominantly the IL-1 type II decoy receptor (IL-1 decoy RII). N-t-Boc-Met-Leu-Phe, an antagonist for the FMLP receptor, inhibited the loss of IL-1 binding capacity induced by FMLP. Monocyte chemotactic protein 1, a chemokine related to IL-8 but inactive on PMN, had no effect on IL-1 binding in this cell type. FMLP was selected for further detailed analysis of chemoattractant-induced loss of IL-1 binding by PMN. The action of FMLP was rapid, reaching 50% of its maximum (80%) at 30 s, the earliest measurable time point, and plateauing between 10 and 30 min. Dose-response analysis revealed that maximal reduction of IL-1 binding was reached at FMLP concentrations that were also optimal for chemotaxis (50% effective dose = 5 x 10(-9) M). The loss of IL-1 binding capacity caused by FMLP was determined by a reduction in receptor number with no change in their affinity. The effect of FMLP on IL-1 receptor (IL-1R) was selective in that the PMN surface structures IL-8R, CD16, CD18, and major histocompatibility complex class I antigens were unaffected under these conditions. Loss of surface IL-1R was not due to an augumented rate of internalization. FMLP caused rapid release of a 45-kD IL-1-binding molecule identified as the IL-1 decoy RII. After FMLP-induced release, PMN reexpressed newly synthesized receptors, reaching basal levels by 4 h. FMLP-induced release of the IL-1 decoy RII did not impair the responsiveness of PMN to IL-1 in terms of promotion of survival and cytokine production. FMLP-induced release of the IL-1 decoy RII was unaffected by protein synthesis inhibitors, was blocked by certain protease inhibitors, and was mimicked by agents (the Ca++ ionophore A23187 and phorbol myristate acetate) that recapitulate elements in the signal transduction pathway of chemoattractant receptors. The time frame and concentration range of chemoattractant-induced rapid release of the IL-1 decoy RII are consistent with the view that IL-1 decoy RII release is an early event in the multistep process of leukocyte recruitment.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

不同类别的趋化因子的代表性分子,包括甲酰甲硫氨酰亮氨酰苯丙氨酸(FMLP)、C5a、白三烯B4、血小板活化因子和白细胞介素(IL)-8,可使人多形核白细胞(PMN)的IL-1结合能力迅速降低,PMN是一种主要表达IL-1 II型诱饵受体(IL-1诱饵RII)的细胞类型。N-叔丁氧羰基甲硫氨酰亮氨酰苯丙氨酸是FMLP受体的拮抗剂,可抑制FMLP诱导的IL-1结合能力丧失。单核细胞趋化蛋白1是一种与IL-8相关但对PMN无活性的趋化因子,对这种细胞类型中的IL-1结合没有影响。选择FMLP对PMN趋化因子诱导的IL-1结合丧失进行进一步详细分析。FMLP的作用迅速,在最早可测量的时间点30秒时达到其最大值(80%)的50%,并在10至30分钟之间达到平稳状态。剂量反应分析表明,在对趋化性也最适宜的FMLP浓度下(50%有效剂量 = 5×10⁻⁹ M),IL-1结合的最大降低得以实现。FMLP导致的IL-1结合能力丧失是由受体数量减少而其亲和力不变所决定的。FMLP对IL-1受体(IL-1R)的作用具有选择性,因为在这些条件下,PMN表面结构IL-8R、CD16、CD18和主要组织相容性复合体I类抗原未受影响。表面IL-1R的丧失并非由于内化速率增加。FMLP导致一种被鉴定为IL-1诱饵RII的45-kD IL-1结合分子迅速释放。FMLP诱导释放后,PMN重新表达新合成的受体,4小时后达到基础水平。FMLP诱导的IL-1诱饵RII释放并不损害PMN在促进存活和细胞因子产生方面对IL-1的反应性。FMLP诱导的IL-1诱饵RII释放不受蛋白质合成抑制剂的影响,被某些蛋白酶抑制剂阻断,并被模拟趋化因子受体信号转导途径中元件的试剂(钙离子载体A23187和佛波酯肉豆蔻酸酯乙酸)所模拟。趋化因子诱导的IL-1诱饵RII快速释放的时间框架和浓度范围与IL-1诱饵RII释放是白细胞募集多步骤过程中的早期事件这一观点一致。(摘要截断于400字)